Dr. Carolyn Cherie, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2737 E Coast Hwy Ste B, Corona Del Mar, CA 92625 Phone: 949-355-9655 |
Dr. Seda Terzyan, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1550 Bayside Dr Ste 2, Corona Del Mar, CA 92625 Phone: 949-783-9590 |
Richard Carl Beuttler, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 19 Skysail Dr, Corona Del Mar, CA 92625 Phone: 949-644-6460 |
Mrs. Linda P Algazi, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8 Point Loma Dr, Corona Del Mar, CA 92625 Phone: 949-244-4074 |
Enas Elshiwick, PSY.D.,MFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2721 E Coast Hwy, Corona Del Mar, CA 92625 Phone: 949-456-0146 |
Dr. Dolly A Platt, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1550 Bayside Dr, Suite 13, Corona Del Mar, CA 92625 Phone: 949-640-6247 Fax: 949-720-8169 |
Dr. Arlene Dorius, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1550 Bayside Dr, Corona Del Mar, CA 92625 Phone: 949-644-6866 |
Dr. Lyndsay Elliott, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1550 Bayside Dr, Ste 6, Corona Del Mar, CA 92625 Phone: 888-917-7924 Fax: 888-830-8285 |
News Archive
Ever stand up too quickly and see stars? Fainting from low blood pressure can be dangerous for astronauts as well as for patients.
Leon Reinstein, M.D., associate physiatrist-in-chief of Sinai Rehabilitation Center, has been given the Frank H. Krusen, M.D., Lifetime Achievement Award by the American Academy of Physical Medicine and Rehabilitation (AAPM&R).
New software advances for the ATLAS® Corneal Topography System were released today by Carl Zeiss Meditec during the American Academy of Optometry meeting in Orlando, Florida. Review Software and MasterFit II™ Contact Lens Software for the ATLAS corneal topography system are designed to make clinical data and images more accessible for eye care providers, while facilitating improved eye care diagnosis and treatment solutions for patients.
Sunovion Pharmaceuticals Inc. today announced that a study evaluating the efficacy and safety of dasotraline in adults with moderate to severe binge eating disorder met its primary endpoint, demonstrating a statistically significant decrease in number of binge days per week from baseline to Week 12 in the group treated with dasotraline 6 mg/day versus the placebo-treated group.
› Verified 4 days ago